Associations of low sex hormone‐binding globulin and androgen excess in early pregnancy with fasting and post‐prandial hyperglycaemia, gestational diabetes, and its severity
Open Access
- 19 December 2022
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 39 (2)
Abstract
Aims: We studied whether androgen excess and low sex hormone‐binding globulin (SHBG) measured in early pregnancy are independently associated with fasting and post‐prandial hyperglycaemia, gestational diabetes (GDM), and its severity.Materials and Methods: This nationwide case–control study included 1045 women with GDM and 963 non‐diabetic pregnant controls. We measured testosterone (T) and SHBG from biobanked serum samples (mean 10.7 gestational weeks) and calculated the free androgen index (FAI). We first studied their associations with GDM and secondly with the type of hyperglycaemia (fasting, 1 and 2 h glucose concentrations during the oral glucose tolerance test), early‐onset GDM (<20 gestational weeks) and the need for anti‐diabetic medication.Results: After adjustments for gestational weeks at sampling, pre‐pregnancy BMI, and age, women with GDM had 3.7% (95% CI 0.1%–7.3%) lower SHBG levels, 3.1% (95% CI 0.1%–6.2%) higher T levels, and 4.6% (95% CI 1.9%–7.3%) higher FAI levels than controls. SHBG was inversely associated with fasting glucose, whereas higher FAI and T were associated with higher post‐prandial glucose concentrations. Women with early‐onset GDM had 6.7% (95% CI 0.7%–12.7%) lower SHBG levels and women who needed insulin for fasting hyperglycaemia 8.7% (95% CI 1.8%–14.8%) lower SHBG levels than other women with GDM.Conclusions: Lower SHBG levels were associated especially with early‐onset GDM, higher fasting glucose and insulin treatment, whereas androgen excess was associated with higher post‐prandial glucose values. Thus, a low SHBG level may reflect the degree of existing insulin resistance, while androgen excess might impair post‐prandial insulin secretion.Keywords
Funding Information
- Medical Research Center Oulu
- Research Council of Finland
This publication has 37 references indexed in Scilit:
- Glycosylated Fibronectin as a First-Trimester Biomarker for Prediction of Gestational DiabetesObstetrics & Gynecology, 2013
- Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeksPrenatal Diagnosis, 2010
- Relationships of Circulating Sex Hormone–Binding Globulin With Metabolic Traits in HumansDiabetes, 2010
- Sex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndromeMolecular and Cellular Endocrinology, 2010
- Pregnancy and Laboratory StudiesObstetrics & Gynecology, 2009
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and MenNew England Journal of Medicine, 2009
- Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone–binding globulin geneJournal of Clinical Investigation, 2007
- Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndromeEuropean Journal of Endocrinology, 2007
- Predicting gestational diabetes: choosing the optimal early serum markerAmerican Journal of Obstetrics and Gynecology, 2007
- Low Levels of Sex-Hormone-Binding Globulin predict insulin requirement in patients with gestational diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 2001